SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention
View/Open
Date
2022-01Author
Collett, Nicola
Rus-Calafell, Mar
East, Anna
Freeman, Daniel
Metadata
Show full item recordCitation
Thomas Ward, Amy Hardy, Rebecca Holm, Nicola Collett, Mar Rus-Calafell, Catarina Sacadura, Alison McGourty, Claire Vella, Anna East3,4 | Michaela Rea1 | Helen Harding, Richard Emsley, Kathryn Greenwood, Daniel Freeman, David Fowler, Elizabeth Kuipers, Paul Bebbington, Philippa Garety. SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention. Psychol Psychother Theory Res Pract. 2021;00:1–24.
Abstract
Objectives: SlowMo therapy is a pioneering blended digital
therapy for paranoia, augmenting face-to-face therapy with
an interactive ‘webapp’ and a mobile app. A recent largescale trial demonstrated small–moderate effects on paranoia
alongside improvements in self-esteem, worry, well-being
and quality of life. This paper provides a comprehensive
account of therapy personalisation within this targeted
approach.
Design: Case examples illustrate therapy delivery and descriptive data are presented on personalised thought content.
Method: Thought content was extracted from the webapp
(n = 140 participants) and coded using newly devised categories: Worries: (1) Persecutory, (2) Negative social evaluation, (3) Negative self-concept, (4) Loss/life stresses, (5)
Sensory-perceptual experiences and (6) Health anxieties.
Safer thoughts: (1) Safer alternative (specific alternatives to
worries), (2) Second-wave (generalised) coping, (3) Positive
self-concept, (4) Positive activities and (5) Third-wave
(mindfulness-based) coping. Data on therapy fidelity are
also presented.
Results: Worries: ‘Persecutory’ (92.9% of people) and
‘Negative social evaluation’ (74.3%) were most common.
‘General worries/ life stresses’ (31.4%) and ‘Negative selfconcept’ (22.1%) were present in a significant minority; ‘Health
anxieties’ (10%) and ‘Sensory-perceptual’ (10%) were less common. Safer thoughts: ‘Second-wave (general) coping’ (85%),
‘Safer alternatives’ (76.4%), ‘Positive self-concept’ (65.7%) and
‘Positive activities’ (64.3%) were common with ‘Third-wave’
(mindfulness) coping observed for 30%. Fidelity: Only three
therapy withdrawals were therapy related. Session adherence
was excellent (mean = 15.2/16; SD = 0.9). Behavioural work
was conducted with 71% of people (119/168).
Conclusion: SlowMo therapy delivers a targeted yet personalised approach. Potential mechanisms of action extend
beyond reasoning. Implications for cognitive models of paranoia and causal interventionist approaches are discussed.
Description
Open access under a Creative Commons License